Registration - Organization

GlaxoSmithKline Inc. / Tina Graves, President and General Manager, GSK Canada

Registration Information

Organization name: GlaxoSmithKline Inc.
Previous Organization names
Senior Officer Name: Tina Graves, President and General Manager, GSK Canada
Senior Officer Change History
Initial registration start date: 2010-05-19
Registration status: Active
Projected end date: No date provided
Registration number: 12493-1576

Associated Lobbying Activity Reports

Total number of Lobbying Activity Reports: 83

Lobbying Activity Reports - last 6 months: 5

Version 18 of 47 (2020-09-01 to 2020-10-06)

Registration versions:

Version 18 of 47 (2020-09-01 to 2020-10-06)

Lobbying Information

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below:

Yes

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Advocacy as it relates to Patended Medicines Pricing Review Board and its potential impact on BC's Life Sciences and Research Community	Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Advanced Education, Economic Development and Trade, Health, Industry
Advocacy related to pharmaceutical and health sciences research	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	Advanced Education, COVID-19, Health, Hospitals, Industry
Discussions regarding pharmaceutical and vaccine procurement, drug and vaccine listings on publicly funded programs and other issues related to access to GSK medicines	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	COVID-19, Emergency Preparedness, Government Procurement, Health, Hospitals
Discussions related to pharmaceutical, vaccine and other health policy generally	Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	COVID-19
GSK will conduct activities related to advancement of GSK medicines and vaccines with stakeholders of the healthcare system.	Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	Advanced Education, COVID-19, Economic Development and Trade, Emergency Preparedness, Health, Hospitals, Industry
GSK will meet to discuss issues related to access to GSK Medicines and Vaccines, clinical trials and advancement of the life sciences industry	Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	Advanced Education, COVID-19, Economic Development and Trade, Emergency Preparedness, Government Procurement, Health, Hospitals, Industry

BC Ministries/Provincial Entities

Advanced Education, Skills and Training
Fraser Health Authority
Health
Innovate BC
Interior Health Authority
Jobs, Economic Development and Competitiveness
Providence Health Care Society
Provincial Health Services Authority
University of British Columbia
University of Victoria
Vancouver Coastal Health Authority
Vancouver Island Health Authority

Organization Details

Senior Officer Name and Position during the Period of this Registration

Faris El Refaie, Vice President and General Manager

Organization Contact Information

GlaxoSmithKline Inc.

Address:
7811 Buena Vista Road
Edmonton, BC T5R 5R3
Canada

Description of Activities

GSK is one of the world's leading research-based pharmaceutical and healthcare companies. GSK is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.ca.gsk.com.

Gifts or benefits provided by the organization

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Contributors to the Lobbying Activity

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of the organization that has a direct interest in the outcome of the lobbying activity.

Government Funding in the Last 12 Months

No government funding was requested or received within the preceding 12 months.

Other Entities (working together for the purposes of lobbying) Information

GlaxoSmithKline Inc. is not working together with any other entity for the purpose of lobbying.

Affiliates with a Direct Interest in the Outcome

ID Biomedical Corporation of Quebec
- 2323 boul. du Parc Technologique
  Quebec, QC G1P 4R8
  Canada
Setfirst Limited
- 980 Great West Road,
  Brenford, Middlesex T8W9Gs
  United Kingdom
SmithKline Beecham Animal Health Company
- Purdy's Wharf Tower One
  Suite 900, 1959 Upper Water Street
  Halifax, NS M3J 2X2
  Canada

Other Persons or Organizations with Direct Interests

The activities of GlaxoSmithKline Inc. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.

Lobbyists Details

Lobbyists Employed by this Organization

Lobbyist

Contributions

Stephen Burke
Subscribes to a Code of Conduct: Yes
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2017-04-11 and before 2020-09-21: Information not required when originally submitted